Evaluation of behavioral and pharmacological effects of hydroalcoholic extract of Valeriana prionophylla Standl. from Guatemala

Evidence-based Complementary and Alternative Medicine

Volumn 2011, Issue , 2011, Pages

  De Souza, Márcia Maria ^a   Holzmann, Iandra ^a   Cechinel Filho, Valdir ^a   Mora, Ticiana C ^a   Cáceres, Armando ^b   Martínez, Jose Vicente ^b   Cruz, Sully M ^b  

^a UNIVERSIDADE DO VALE DO ITAJAÍ   (Brazil)

^b UNIVERSIDAD DE SAN CARLOS DE GUATEMALA   (Guatemala)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; DIAZEPAM; HYPNOTIC SEDATIVE AGENT; LORAZEPAM; PENTOBARBITAL; PLANT EXTRACT; STRYCHNINE; UNCLASSIFIED DRUG; VALERIANA PRIONOPHYLLA EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FORCED SWIMMING TEST; IMMOBILIZATION; MALE; MAZE TEST; MEMORY CONSOLIDATION; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; RAT; RHIZOME; SEIZURE; SLEEP DISORDER; SLEEP TIME; TRANQUILIZING ACTIVITY; VALERIANA; VALERIANA PRIONOPHYLLA;

EID: 80052782952     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2011/312320     Document Type: Article

References (62)

1. Ohayon M. M., Roth T., What are the contributing factors for insomnia in the general population? Journal of Psychosomatic Research 2001 51 6 745 755 (Pubitemid 34055801)
2. Roth T., Drake C., Evolution of insomnia: current status and future direction Sleep Medicine 2004 5 1 S23 S30
3. Lieb R., Becker E., Altamura C., The epidemiology of generalized anxiety disorder in Europe European Neuropsychopharmacology 2005 15 4 445 452 (Pubitemid 40943548)
4. Carlini E. A., Rodrigues E., Mendes F. R., Tabach R., Gianfratti B., Treatment of drug dependence with Brazilian herbal medicines Revista Brasileira de Farmacognosia 2006 16 690 695
5. Carlini E. A., Plants and the central nervous system Pharmacology Biochemistry and Behavior 2003 75 3 501 512 (Pubitemid 36936886)
6. WHO, Radix valerianae WHO Monographs on Selected Medicinal Plants 1999 1 267 276
7. Valerianae radix ESCOP Monographs 2003 Exeter, UK Thieme 539 546
8. Mellen G. A., El uso de las plantas Medicinales en Guatemala Guatemala Indgena 1974 9 102 148
9. Nicolas J. P., Plantes médicinales des mayas K'iché du Guatemala 1999 Paris, France Lbis Press
10. Cruz A. R., Evaluacin de la actividad biocida e identificacin qumica de valepotriatos en tres plantas reconocidas popularmente en Guatemala como Valeriana, Thesis 2005 Guatemala Facultad de Ciencias Qumicas y Farmacia USAC
11. Nash D. L., Dieterle J. V. A., Flora of Guatemala Fieldiana: Botany 1976 24 11 297
12. Chavadej S., Becker A., Weberling F., Further investigations of valepotriates in the Valerianaceae Pharmaceutisch Weekblad 1985 7 4 167 168 (Pubitemid 15020681)
13. Piccinelli A., Arana S., Cceres A., Villa Bianca R. E., Sorrentino R., Rastrelli L., New lignans from the roots of Valeriana prionophylla with antioxidative and vasorelaxant activities Journal of Natural Products 2004 67 7 1135 1140 (Pubitemid 38971674)
14. Roca C. R., Evaluacin comparativa de la accin sedante e hipntica de un elixir fitoterapéutico y la combinacin de las plantas originales, Thesis 2005 Guatemala Facultad de Ciencias Qumicas y Farmacia USAC
15. Cruz E. C., Evaluacin clnica de la efectividad de Valeriana prionophylla como inductora del sueo, M.S. thesis 2005 Guatemala Facultad de Ciencias Qumicas y Farmacia USAC
16. Cceres A., Vademécum Nacional de Plantas Medicinales 2006 Guatemala Universidad de San Carlos
17. Sharapin N., Fundamentos de Tecnologa de Productos Fitoterapé uticos 2000 Santafé de Bogot, Colombia CAB-CYTED
18. COBEA,. http://vsites.unb.br/ib/ceua/COBEA.htm
19. sugimoto Y., Furutani S., Itoh A., Tanahashi T., Nakajima H., Oshiro H., Sun S., Yamada J., Effects of extracts and neferine from the embryo of Nelumbo nucifera seeds on the central nervous system Phytomedicine 2008 15 12 1117 1124
20. Archer J., Tests for emotionality in rats and mice: a review Animal Behaviour 1973 21 2 205 235
21. Fernndez S., Wasowski C., Paladini A. C., Marder M., Sedative and sleep-enhancing properties of linarin, a flavonoid-isolated from Valeriana officinalis Pharmacology Biochemistry and Behavior 2004 77 2 399 404 (Pubitemid 38125174)
22. De Souza M. M., Schenberg L. C., de Pdua Carobrez A., NMDA-coupled periaqueductal gray glycine receptors modulate anxioselective drug effects on plus-maze performance Behavioural Brain Research 1998 90 2 157 165 (Pubitemid 28080557)
23. Arago C., Corte-Real J., Costas B., Dinis M. T., Conceio L. E., Stress response and changes in amino acid requirements in Senegalese sole (Solea senegalensis Kaup 1858) Amino Acids 2008 34 1 143 148
24. Cryan J. F., Page M. E., Lucki I., Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test European Journal of Pharmacology 2002 436 3 197 205 (Pubitemid 34164699)
25. Porsolt R. D., Bertin A., Jalfre M., Behavioral despair in mice: a primary screening test for antidepressants Archives Internationales de Pharmacodynamie et de Therapie 1977 229 2 327 336 (Pubitemid 8225714)
26. Ali A., Ahmad F. J., Pillai K. K., Vohora D., Evidence of the antiepileptic potential of amiloride with neuropharmacological benefits in rodent models of epilepsy and behavior Epilepsy and Behavior 2004 5 3 322 328 (Pubitemid 38950091)
27. Yamashita H., Ohno K., Amada Y., Hattori H., Osawa-Funatsu Y., Toya T., Inami H., Shishikura J. I., Sakamoto S., Okada M., Yamaguchi T., Effects of 2-[N-(4-chlorophenyl)-N-methylamino]-4H-pyrido[3.2-e]-1,3-thiazin-4-one (YM928), an orally active alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, in models of generalized epileptic seizure in mice and rats Journal of Pharmacology and Experimental Therapeutics 2004 308 1 127 133 (Pubitemid 38090710)
28. Izquierdo I., Cammarota M., Medina J. H., Bevilaqua L. R., Pharmacological findings on the biochemical bases of memory processes: a general view Neural Plasticity 2004 11 3-4 159 189 (Pubitemid 40123735)
29. De Souza M. M., Mello e Souza T., Vinade E. R., Rodrigues C., Choi H. K., Dedavid T. L., Medina J. H., Izquierdo I., Effects of posttraining treatments in the posterior cingulate crtex on short- and long-term memory for inhibithory avoidance in rats Neurobiology of Learning and Memory 2002 77 2 202 210 (Pubitemid 34971652)
30. Morais L. C., Barbosa-Filho J. M., Almeida R. N., Central depressant effects of reticuline extracted from Ocotea duckei in rats and mice Journal of Ethnopharmacology 1998 62 1 57 61 (Pubitemid 28369724)
31. Hattesohl M., Feistel B., Sievers H., Lehnfeld R., Hegger M., Winterhoff H., Extracts of Valeriana officinalis L. s.l. show anxiolytic and antidepressant effects but neither sedative nor myorelaxant properties Phytomedicine 2008 15 1-2 2 15 (Pubitemid 50021760)
32. Petty F., GABA and mood disorders: a brief review and hypothesis Journal of Affective Disorders 1995 34 4 275 281
33. Masur J., Mrtz R. M., Carlini E. A., Effects of acute and chronic administration of cannabis sativa and (-)9 -trans-tetrahydrocannabinol on the behavior of rats in an open-field arena Psychopharmacologia 1971 19 4 388 397
34. Yadav A. V., Kawale L. A., Nade V. S., Effect of Morus alba L. (mulberry) leaves on anxiety in mice Indian Journal of Pharmacology 2008 40 1 32 36
35. Jackson M. J., Turkington D., Depression and anxiety in epilepsy Journal of Neurology, Neurosurgery and Psychiatry 2005 76 1 45 47
36. Rodgers R. J., Johnson N. J., Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety Pharmacology Biochemistry and Behavior 1995 52 2 297 303
37. Nic Dhonnchadha B. A., Bourin M., Hascot M., Anxiolytic-like effects of 5-HT 2 ligands on three mouse models of anxiety Behavioural Brain Research 2003 140 1-2 203 214 (Pubitemid 36321745)
38. Pellow S., File S. E., The effects of putative anxiogenic compounds (FG 7142, CGS 8216 and Ro 15-1788) on the rat corticosterone response Physiology and Behavior 1985 35 4 587 590 (Pubitemid 16237712)
39. File S. E., Zangrossi H. Jr., Andrews N., Social interaction and elevated plus-maze tests: changes in release and uptake of 5-HT and GABA Neuropharmacology 1993 32 3 217 221 (Pubitemid 23085265)
40. Treit D., Fundytus M., Thigmotaxis as a test for anxiolytic activity in rats Pharmacology Biochemistry and Behavior 1988 31 4 959 962 (Pubitemid 19274312)
41. Marder M., Viola H., Wasowski C., Fernndez S., Medina J. H., Paladini A. C., 6-methylapigenin and hesperidin: new valeriana flavonoids with activity on the CNS Pharmacology Biochemistry and Behavior 2003 75 3 537 545 (Pubitemid 36936888)
42. Herrera-Ruiz M., Jiménez-Ferrer J. E., De Lima T. C., Avilés-Montes D., Pérez-Garca D., Gonzlez-Cortazar M., Tortoriello J., Anxiolytic and antidepressant-like activity of a standardized extract from Galphimia glauca Phytomedicine 2006 13 1-2 23 28 (Pubitemid 41797587)
43. Porsolt R. D., Anton G., Blavet N., Jalfre M., Behavioural despair in rats: a new model sensitive to antidepressant treatments European Journal of Pharmacology 1978 47 4 379 391
44. Anisman H., Matheson K., Stress, depression, and anhedonia: caveats concerning animal models Neuroscience and Biobehavioral Reviews 2005 29 4-5 525 546 (Pubitemid 40755455)
45. Matthews K., Christmas D., Swan J., Sorrell E., Animal models of depression: navigating through the clinical fog Neuroscience and Biobehavioral Reviews 2005 29 4-5 503 513 (Pubitemid 40755454)
46. Lapiz-Bluhm M. D., Bondi C. O., Doyen J., Rodriguez G. A., Bédard-Arana T., Morilak D. A., Behavioural assays to model cognitive and affective dimensions of depression and anxiety in rats Journal of Neuroendocrinology 2008 20 10 1115 1137
47. Porsolt R. D., Le Pichon M., Jalfre M., Depression: a new animal model sensitive to antidepressant treatments Nature 1977 266 5604 730 732 (Pubitemid 8073804)
48. Galea L. A., Wide J. K., Barr A. M., Estradiol alleviates depressive-like symptoms in a novel animal model of post-partum depression Behavioural Brain Research 2001 122 1 1 9 (Pubitemid 32241787)
49. Barton C., Sklenicka J., Sayegh P., Yaffe K., Contraindicated medication use among patients in a memory disorders clinic American Journal Geriatric Pharmacotherapy 2008 6 3 147 152
50. Rezvani M. E., Roohbakhsh A., Allahtavakoli M., Shamsizadeh A., Anticonvulsant effect of aqueous extract of Valeriana officinalis in amygdala-kindled rats: possible involvement of adenosine Journal of Ethnopharmacology 2010 127 2 313 318
51. Hendriks H., Bos R., Woerdenbag H. J., Koster S., Central nervous depressant activity of valerenic acid in the mouse Planta Medica 1985 1 28 31 (Pubitemid 15146408)
52. De Feo V., Faro C., Pharmacological effects of extracts from Valeriana adscendens: effects on GABA uptake and amino acids Phytotherapy Research 2003 17 6 661 664 (Pubitemid 36781744)
53. Bent S., Padula A., Moore D., Patterson M., Mehling W., Valerian for sleep: a systematic review and meta-analysis American Journal of Medicine 2006 119 12 1005 1012 (Pubitemid 44826933)
54. Khom S., Strommer B., Ramharter J., Valerenic acid derivatives as novel subunit-selective GABAA receptor ligandsin vitro and in vivo characterization British Journal of Pharmacology 2010 161 1 65 78
55. Khom S., Barburin I., Timin E., Valerenic acid potentiates and inhibits GABAA receptors: molecular mechanism and subunit specificity Neuropharmacol 2007 53 178 187 (Pubitemid 47125958)
56. Yuan C. S., Mehendale S., Xiao Y., Aung H. H., Xie J. T., Ang-Lee M. K., The GABAergic effects of valerian and valerenic acid on rat brain stem neuronal activity Anesthesia and Analgesia 2004 98 2 353 358 (Pubitemid 38129379)
57. Benke D., Barberis A., Kopp S., Altmann K. H., Schubiger M., Vogt K. E., Rudolph U., Mhler H., GABAA receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts Neuropharmacology 2009 56 1 174 181
58. Schumacher B., Scholle S., Hlzl J., Khudeir N., Hess S., Mller C. E., Lignans isolated from Valerian: identification and characterization of a new olivil derivative with partial agonistic activity at A 1 adenosine receptors Journal of Natural Products 2002 65 10 1479 1485 (Pubitemid 35239637)
59. Sichardt K., Vissiennon Z., Koetter U., Brattstrm A., Nieber K., Modulation of postsynaptic potentials in rat cortical neurons by valerian extracts macerated with different alcohols: involvement of adenosine A 1-and GABAA -receptors Phytotherapy Research 2007 21 10 932 937 (Pubitemid 47582766)
60. Lacher S. K., Mayer R., Sichardt K., Nieber K., Mller C. E., Interaction of valerian extracts of different polarity with adenosine receptors: identification of isovaltrate as an inverse agonist at A 1 receptors Biochemical Pharmacology 2007 73 2 248 258 (Pubitemid 44855728)
61. Vissiennon Z., Sichardt K., Koetter U., Brattstrm A., Nieber K., Valerian extract Ze 911 inhibits postsynaptic potentials by activation of adenosine A 1 receptors in rat cortical neurons Planta Medica 2006 72 7 579 583
62. Wasowski C., Marder M., Viola H., Medina J. H., Paladini A. C., Isolation and identification of 6-methylapigenin, a competitive ligand for the brain GABAA receptors, from Valeriana wallichii Planta Medica 2002 68 10 934 936 (Pubitemid 35239288)